Endpoint of the economic evaluation | Derived from/questionnaire name | Time of measurement (Month) | |||||
---|---|---|---|---|---|---|---|
 |  | Baseline | M 3 | M 6 | M 9 | M 12 | M 15 |
Incidence rate of depression | Depression module of the SCID | X | X | Â | Â | Â | X |
Severity of depression | QIDS/Hamilton Scale | X | X | Â | Â | X | X |
QALYs | SF-36 EQ-5D | X | X | X | X | X | X |
MCI (three-step screening) | Interview of Strawbridge MMSE CDR SKT + MWTB | X | Â | Â | Â | Â | X* |
Health sector and patients' costs | Cost questionnaire | X | Â | X | Â | X | X |
Laboratory parameters | Safety parameters: ALT, AST, creatinine, TSH | X | Â | Â | Â | Â | Â |
 | HbA1c | X | X | X | X | X | X |
Diabetes-related emotional distress, coping, diabetes self-care activities | PAID SDSCA FKV-15 | X | X | Â | Â | X | X |
Interpersonal aspects | SE H-Skala K-INK | X | X | Â | Â | X | X |